BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Emptoz A, Michel V, Lelli A, Akil O, Boutet de Monvel J, Lahlou G, Meyer A, Dupont T, Nouaille S, Ey E, Franca de Barros F, Beraneck M, Dulon D, Hardelin JP, Lustig L, Avan P, Petit C, Safieddine S. Local gene therapy durably restores vestibular function in a mouse model of Usher syndrome type 1G. Proc Natl Acad Sci U S A 2017;114:9695-700. [PMID: 28835534 DOI: 10.1073/pnas.1708894114] [Cited by in Crossref: 55] [Cited by in F6Publishing: 52] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang L, Kempton JB, Brigande JV. Gene Therapy in Mouse Models of Deafness and Balance Dysfunction. Front Mol Neurosci 2018;11:300. [PMID: 30210291 DOI: 10.3389/fnmol.2018.00300] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
2 Zhu J, Choi JW, Ishibashi Y, Isgrig K, Grati M, Bennett J, Chien W. Refining surgical techniques for efficient posterior semicircular canal gene delivery in the adult mammalian inner ear with minimal hearing loss. Sci Rep 2021;11:18856. [PMID: 34552193 DOI: 10.1038/s41598-021-98412-y] [Reference Citation Analysis]
3 Wang J, Puel J. Toward Cochlear Therapies. Physiological Reviews 2018;98:2477-522. [DOI: 10.1152/physrev.00053.2017] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 9.3] [Reference Citation Analysis]
4 Calabro KR, Boye SL, Choudhury S, Fajardo D, Peterson JJ, Li W, Crosson SM, Kim MJ, Ding D, Salvi R, Someya S, Boye SE. A Novel Mouse Model of MYO7A USH1B Reveals Auditory and Visual System Haploinsufficiencies. Front Neurosci 2019;13:1255. [PMID: 31824252 DOI: 10.3389/fnins.2019.01255] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Géléoc GGS, El-Amraoui A. Disease mechanisms and gene therapy for Usher syndrome. Hear Res 2020;394:107932. [PMID: 32199721 DOI: 10.1016/j.heares.2020.107932] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
6 Sayyid ZN, Kim GS, Cheng AG. Molecular therapy for genetic and degenerative vestibular disorders. Curr Opin Otolaryngol Head Neck Surg 2018;26:307-11. [PMID: 30045104 DOI: 10.1097/MOO.0000000000000477] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
7 Akil O. Dual and triple AAV delivery of large therapeutic gene sequences into the inner ear. Hearing Research 2020;394:107912. [DOI: 10.1016/j.heares.2020.107912] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
8 Verdoodt D, Peeleman N, Van Camp G, Van Rompaey V, Ponsaerts P. Transduction Efficiency and Immunogenicity of Viral Vectors for Cochlear Gene Therapy: A Systematic Review of Preclinical Animal Studies. Front Cell Neurosci 2021;15:728610. [PMID: 34526880 DOI: 10.3389/fncel.2021.728610] [Reference Citation Analysis]
9 Kleinlogel S, Vogl C, Jeschke M, Neef J, Moser T. Emerging approaches for restoration of hearing and vision. Physiological Reviews. [DOI: 10.1152/physrev.00035.2019] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
10 Toms M, Pagarkar W, Moosajee M. Usher syndrome: clinical features, molecular genetics and advancing therapeutics. Ther Adv Ophthalmol 2020;12:2515841420952194. [PMID: 32995707 DOI: 10.1177/2515841420952194] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
11 Mei C, Dong H, Nisenbaum E, Thielhelm T, Nourbakhsh A, Yan D, Smeal M, Lundberg Y, Hoffer ME, Angeli S, Telischi F, Nie G, Blanton SH, Liu X. Genetics and the Individualized Therapy of Vestibular Disorders. Front Neurol 2021;12:633207. [PMID: 33613440 DOI: 10.3389/fneur.2021.633207] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Blanc F, Mondain M, Bemelmans AP, Affortit C, Puel JL, Wang J. rAAV-Mediated Cochlear Gene Therapy: Prospects and Challenges for Clinical Application. J Clin Med 2020;9:E589. [PMID: 32098144 DOI: 10.3390/jcm9020589] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
13 Dombrowski T, Rankovic V, Moser T. Toward the Optical Cochlear Implant. Cold Spring Harb Perspect Med 2019;9:a033225. [PMID: 30323016 DOI: 10.1101/cshperspect.a033225] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
14 Calvet C, Lahlou G, Safieddine S. [Gene therapy progress: hopes for Usher syndrome]. Med Sci (Paris) 2018;34:842-8. [PMID: 30451679 DOI: 10.1051/medsci/2018210] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
15 Dulon D, Papal S, Patni P, Cortese M, Vincent PF, Tertrais M, Emptoz A, Tlili A, Bouleau Y, Michel V, Delmaghani S, Aghaie A, Pepermans E, Alegria-Prevot O, Akil O, Lustig L, Avan P, Safieddine S, Petit C, El-Amraoui A. Clarin-1 gene transfer rescues auditory synaptopathy in model of Usher syndrome. J Clin Invest 2018;128:3382-401. [PMID: 29985171 DOI: 10.1172/JCI94351] [Cited by in Crossref: 48] [Cited by in F6Publishing: 34] [Article Influence: 12.0] [Reference Citation Analysis]
16 Atkinson PJ, Kim GS, Cheng AG. Direct cellular reprogramming and inner ear regeneration. Expert Opin Biol Ther 2019;19:129-39. [PMID: 30584811 DOI: 10.1080/14712598.2019.1564035] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
17 Whatley M, Francis A, Ng ZY, Khoh XE, Atlas MD, Dilley RJ, Wong EYM. Usher Syndrome: Genetics and Molecular Links of Hearing Loss and Directions for Therapy. Front Genet 2020;11:565216. [PMID: 33193648 DOI: 10.3389/fgene.2020.565216] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
18 Hastings ML, Brigande JV. Fetal gene therapy and pharmacotherapy to treat congenital hearing loss and vestibular dysfunction. Hear Res 2020;394:107931. [PMID: 32173115 DOI: 10.1016/j.heares.2020.107931] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
19 Yoshimura H, Shibata SB, Ranum PT, Moteki H, Smith RJH. Targeted Allele Suppression Prevents Progressive Hearing Loss in the Mature Murine Model of Human TMC1 Deafness. Mol Ther 2019;27:681-90. [PMID: 30686588 DOI: 10.1016/j.ymthe.2018.12.014] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 10.7] [Reference Citation Analysis]
20 Lustig L, Akil O. Cochlear Gene Therapy. Cold Spring Harb Perspect Med 2019;9:a033191. [PMID: 30323014 DOI: 10.1101/cshperspect.a033191] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
21 Kang W, Zhao X, Sun Z, Dong T, Jin C, Tong L, Zhu W, Tao Y, Wu H. Adeno-associated virus vector enables safe and efficient Cas9 activation in neonatal and adult Cas9 knockin murine cochleae. Gene Ther 2020;27:392-405. [PMID: 32005950 DOI: 10.1038/s41434-020-0124-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
22 Akil O, Dyka F, Calvet C, Emptoz A, Lahlou G, Nouaille S, Boutet de Monvel J, Hardelin JP, Hauswirth WW, Avan P, Petit C, Safieddine S, Lustig LR. Dual AAV-mediated gene therapy restores hearing in a DFNB9 mouse model. Proc Natl Acad Sci U S A 2019;116:4496-501. [PMID: 30782832 DOI: 10.1073/pnas.1817537116] [Cited by in Crossref: 69] [Cited by in F6Publishing: 57] [Article Influence: 23.0] [Reference Citation Analysis]
23 Schilder AG, Su MP, Mandavia R, Anderson CR, Landry E, Ferdous T, Blackshaw H. Early phase trials of novel hearing therapeutics: Avenues and opportunities. Hearing Research 2019;380:175-86. [DOI: 10.1016/j.heares.2019.07.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
24 Liu Y, Wei M, Mao X, Chen T, Lin P, Wang W. Key Signaling Pathways Regulate the Development and Survival of Auditory Hair Cells. Neural Plast 2021;2021:5522717. [PMID: 34194486 DOI: 10.1155/2021/5522717] [Reference Citation Analysis]
25 Gu X, Wang D, Xu Z, Wang J, Guo L, Chai R, Li G, Shu Y, Li H. Prevention of acquired sensorineural hearing loss in mice by in vivo Htra2 gene editing. Genome Biol 2021;22:86. [PMID: 33752742 DOI: 10.1186/s13059-021-02311-4] [Reference Citation Analysis]
26 Roccio M. Directed differentiation and direct reprogramming: Applying stem cell technologies to hearing research. Stem Cells 2021;39:375-88. [PMID: 33378797 DOI: 10.1002/stem.3315] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
27 Peusner KD, Bell NM, Hirsch JC, Beraneck M, Popratiloff A. Understanding the Pathophysiology of Congenital Vestibular Disorders: Current Challenges and Future Directions. Front Neurol 2021;12:708395. [PMID: 34589045 DOI: 10.3389/fneur.2021.708395] [Reference Citation Analysis]
28 Michalski N, Petit C. Central auditory deficits associated with genetic forms of peripheral deafness. Hum Genet 2021. [PMID: 34435241 DOI: 10.1007/s00439-021-02339-3] [Reference Citation Analysis]
29 Levie C, Moyaert J, Janssens de Varebeke S, Verdoodt D, Vanderveken OM, Topsakal V, Van Wijk E, de Vrieze E, Pennings R, Van de Berg R, Van Camp G, Ponsaerts P, Van Rompaey V. Attitudes of Potential Participants Towards Potential Gene Therapy Trials in Autosomal Dominant Progressive Sensorineural Hearing Loss. Otol Neurotol 2021;42:384-9. [PMID: 33555744 DOI: 10.1097/MAO.0000000000002981] [Reference Citation Analysis]
30 Delmaghani S, El-Amraoui A. Inner Ear Gene Therapies Take Off: Current Promises and Future Challenges. J Clin Med 2020;9:E2309. [PMID: 32708116 DOI: 10.3390/jcm9072309] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
31 Van De Water TR. Historical Aspects of Gene Therapy and Stem Cell Therapy in the Treatment of Hearing and Balance Disorder. Anat Rec 2019;303:390-407. [DOI: 10.1002/ar.24332] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
32 Akil O, Lustig L. AAV-Mediated Gene Delivery to the Inner Ear. Methods Mol Biol 2019;1950:271-82. [PMID: 30783980 DOI: 10.1007/978-1-4939-9139-6_16] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
33 Botto C, Dalkara D, El-Amraoui A. Progress in Gene Editing Tools and Their Potential for Correcting Mutations Underlying Hearing and Vision Loss. Front Genome Ed 2021;3:737632. [PMID: 34778871 DOI: 10.3389/fgeed.2021.737632] [Reference Citation Analysis]
34 Thorpe RK, Smith RJH. Future directions for screening and treatment in congenital hearing loss. Precis Clin Med 2020;3:175-86. [PMID: 33209510 DOI: 10.1093/pcmedi/pbaa025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
35 de Joya EM, Colbert BM, Tang PC, Lam BL, Yang J, Blanton SH, Dykxhoorn DM, Liu X. Usher Syndrome in the Inner Ear: Etiologies and Advances in Gene Therapy. Int J Mol Sci 2021;22:3910. [PMID: 33920085 DOI: 10.3390/ijms22083910] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Bankoti K, Generotti C, Hwa T, Wang L, O'Malley BW Jr, Li D. Advances and challenges in adeno-associated viral inner-ear gene therapy for sensorineural hearing loss. Mol Ther Methods Clin Dev 2021;21:209-36. [PMID: 33850952 DOI: 10.1016/j.omtm.2021.03.005] [Reference Citation Analysis]
37 French LS, Mellough CB, Chen FK, Carvalho LS. A Review of Gene, Drug and Cell-Based Therapies for Usher Syndrome. Front Cell Neurosci 2020;14:183. [PMID: 32733204 DOI: 10.3389/fncel.2020.00183] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
38 Nourbakhsh A, Colbert BM, Nisenbaum E, El-Amraoui A, Dykxhoorn DM, Koehler KR, Chen ZY, Liu XZ. Stem Cells and Gene Therapy in Progressive Hearing Loss: the State of the Art. J Assoc Res Otolaryngol 2021;22:95-105. [PMID: 33507440 DOI: 10.1007/s10162-020-00781-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
39 Hu CJ, Lu YC, Tsai YH, Cheng HY, Takeda H, Huang CY, Xiao R, Hsu CJ, Tsai JW, Vandenberghe LH, Wu CC, Cheng YF. Efficient in Utero Gene Transfer to the Mammalian Inner Ears by the Synthetic Adeno-Associated Viral Vector Anc80L65. Mol Ther Methods Clin Dev 2020;18:493-500. [PMID: 32775487 DOI: 10.1016/j.omtm.2020.06.019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
40 Zhao X, Jin C, Dong T, Sun Z, Zheng X, Feng B, Cheng Z, Li X, Tao Y, Wu H. Characterization of promoters for adeno-associated virus mediated efficient Cas9 activation in adult Cas9 knock-in murine cochleae. Hear Res 2020;394:107999. [PMID: 32611519 DOI: 10.1016/j.heares.2020.107999] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
41 Lee J, Nist-Lund C, Solanes P, Goldberg H, Wu J, Pan B, Schneider BL, Holt JR. Efficient viral transduction in mouse inner ear hair cells with utricle injection and AAV9-PHP.B. Hear Res 2020;394:107882. [PMID: 31980281 DOI: 10.1016/j.heares.2020.107882] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 8.0] [Reference Citation Analysis]
42 Isgrig K, Chien WW. Surgical Methods for Inner Ear Gene Delivery in Neonatal Mouse. Methods Mol Biol 2019;1937:221-6. [PMID: 30706399 DOI: 10.1007/978-1-4939-9065-8_13] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
43 Van Rompaey V. Making the Case for Research on Disease-Modifying Treatments to Tackle Post-lingual Progressive Sensorineural Hearing Loss. Front Neurol 2020;11:290. [PMID: 32373054 DOI: 10.3389/fneur.2020.00290] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
44 Zhang W, Kim SM, Wang W, Cai C, Feng Y, Kong W, Lin X. Cochlear Gene Therapy for Sensorineural Hearing Loss: Current Status and Major Remaining Hurdles for Translational Success. Front Mol Neurosci 2018;11:221. [PMID: 29997477 DOI: 10.3389/fnmol.2018.00221] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 5.5] [Reference Citation Analysis]
45 Askew C, Chien WW. Adeno-associated virus gene replacement for recessive inner ear dysfunction: Progress and challenges. Hear Res 2020;394:107947. [PMID: 32247629 DOI: 10.1016/j.heares.2020.107947] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
46 Dinculescu A, Link BA, Saperstein DA. Retinal Gene Therapy for Usher Syndrome: Current Developments, Challenges, and Perspectives. Int Ophthalmol Clin 2021;61:109-24. [PMID: 34584048 DOI: 10.1097/IIO.0000000000000378] [Reference Citation Analysis]
47 Leake PA, Akil O, Lang H. Neurotrophin gene therapy to promote survival of spiral ganglion neurons after deafness. Hear Res 2020;394:107955. [PMID: 32331858 DOI: 10.1016/j.heares.2020.107955] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
48 Wang L, Kempton JB, Jiang H, Jodelka FM, Brigande AM, Dumont RA, Rigo F, Lentz JJ, Hastings ML, Brigande JV. Fetal antisense oligonucleotide therapy for congenital deafness and vestibular dysfunction. Nucleic Acids Res 2020;48:5065-80. [PMID: 32249312 DOI: 10.1093/nar/gkaa194] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
49 Taiber S, Avraham KB. Genetic Therapies for Hearing Loss: Accomplishments and Remaining Challenges. Neurosci Lett 2019;713:134527. [PMID: 31586696 DOI: 10.1016/j.neulet.2019.134527] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
50 Crane R, Conley SM, Al-Ubaidi MR, Naash MI. Gene Therapy to the Retina and the Cochlea. Front Neurosci 2021;15:652215. [PMID: 33815052 DOI: 10.3389/fnins.2021.652215] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
51 Cassel R, Bordiga P, Carcaud J, Simon F, Beraneck M, Le Gall A, Benoit A, Bouet V, Philoxene B, Besnard S, Watabe I, Pericat D, Hautefort C, Assie A, Tonetto A, Dyhrfjeld-Johnsen J, Llorens J, Tighilet B, Chabbert C. Morphological and functional correlates of vestibular synaptic deafferentation and repair in a mouse model of acute-onset vertigo. Dis Model Mech 2019;12:dmm039115. [PMID: 31213478 DOI: 10.1242/dmm.039115] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
52 Tertrais M, Bouleau Y, Emptoz A, Belleudy S, Sutton RB, Petit C, Safieddine S, Dulon D. Viral Transfer of Mini-Otoferlins Partially Restores the Fast Component of Exocytosis and Uncovers Ultrafast Endocytosis in Auditory Hair Cells of Otoferlin Knock-Out Mice. J Neurosci 2019;39:3394-411. [PMID: 30833506 DOI: 10.1523/JNEUROSCI.1550-18.2018] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
53 Roccio M, Edge ASB. Inner ear organoids: new tools to understand neurosensory cell development, degeneration and regeneration. Development. 2019;146:dev177188. [PMID: 31477580 DOI: 10.1242/dev.177188] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
54 Isgrig K, McDougald DS, Zhu J, Wang HJ, Bennett J, Chien WW. AAV2.7m8 is a powerful viral vector for inner ear gene therapy. Nat Commun 2019;10:427. [PMID: 30683875 DOI: 10.1038/s41467-018-08243-1] [Cited by in Crossref: 53] [Cited by in F6Publishing: 47] [Article Influence: 17.7] [Reference Citation Analysis]